VEGFA and Abnormal retinal morphology: The crucial role of β3-ARs in vasodilator responses to adrenaline of retinal arterioles was shown and overall, they showed that β3-agonist–induced vascular endothelial growth factor release can be a key factor in many hypoxic-ischemic–related retinal diseases, suggesting that the blocking of β3-ARs may lead to therapeutic tools.42